141 related articles for article (PubMed ID: 3969014)
1. Treatment of osteoporosis with calcitonin, with and without growth hormone.
Aloia JF; Vaswani A; Kapoor A; Yeh JK; Cohn SH
Metabolism; 1985 Feb; 34(2):124-9. PubMed ID: 3969014
[TBL] [Abstract][Full Text] [Related]
2. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.
Aloia JF; Vaswani A; Meunier PJ; Edouard CM; Arlot ME; Yeh JK; Cohn SH
Calcif Tissue Int; 1987 May; 40(5):253-9. PubMed ID: 2981045
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy for osteoporosis.
Aloia JF; Zanzi I; Vaswani A; Ellis K; Cohn SH
Metabolism; 1977 Jul; 26(7):787-92. PubMed ID: 559229
[TBL] [Abstract][Full Text] [Related]
4. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.
Reginster JY; Denis D; Albert A; Deroisy R; Lecart MP; Fontaine MA; Lambelin P; Franchimont P
Lancet; 1987 Dec; 2(8574):1481-3. PubMed ID: 2892047
[TBL] [Abstract][Full Text] [Related]
5. Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
Resch H; Pietschmann P; Willvonseder R
Calcif Tissue Int; 1989 Oct; 45(4):209-13. PubMed ID: 2509007
[TBL] [Abstract][Full Text] [Related]
6. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
Kuntz D; Marie P; Berhel M; Caulin F
Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
[TBL] [Abstract][Full Text] [Related]
7. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
[TBL] [Abstract][Full Text] [Related]
8. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.
Mazzuoli GF; Passeri M; Gennari C; Minisola S; Antonelli R; Valtorta C; Palummeri E; Cervellin GF; Gonnelli S; Francini G
Calcif Tissue Int; 1986 Jan; 38(1):3-8. PubMed ID: 3079649
[TBL] [Abstract][Full Text] [Related]
9. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
Pacifici R; McMurtry C; Vered I; Rupich R; Avioli LV
J Clin Endocrinol Metab; 1988 Apr; 66(4):747-53. PubMed ID: 3126214
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.
Eriksson SA; Lindgren JU
Calcif Tissue Int; 1993 Jul; 53(1):26-8. PubMed ID: 8348381
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcitonin and vitamin D in osteoporosis.
Palmieri GM; Pitcock JA; Brown P; Karas JG; Roen LJ
Calcif Tissue Int; 1989 Sep; 45(3):137-41. PubMed ID: 2505903
[TBL] [Abstract][Full Text] [Related]
13. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.
Tekeoğlu I; Adak B; Budancamanak M; Demirel A; Ediz L
Rheumatol Int; 2005 Dec; 26(2):157-61. PubMed ID: 15660234
[TBL] [Abstract][Full Text] [Related]
15. Salmon calcitonin in the therapy of corticoid-induced osteoporosis.
Ringe JD; Welzel D
Eur J Clin Pharmacol; 1987; 33(1):35-9. PubMed ID: 3319638
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
[TBL] [Abstract][Full Text] [Related]
17. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
Kung AW; Yeung SS
J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
[TBL] [Abstract][Full Text] [Related]
18. The role of skeletal calcium deficiency in postmenopausal osteoporosis.
Burnell JM; Baylink DJ; Chesnut CH; Teubner EJ
Calcif Tissue Int; 1986 Apr; 38(4):187-92. PubMed ID: 3085896
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcitonin on total body bone mineral contents of experimental osteoporotic rats determined by dual photon absorptiometry.
Nakatsuka K; Nishizawa Y; Hagiwara S; Koyama H; Miki T; Ochi H; Morii H
Calcif Tissue Int; 1990 Dec; 47(6):378-82. PubMed ID: 2292081
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
